Makale
Tam Makale
Uluslararası
2018
Comparison of long-term outcomes of 50 and 100mg rt-PA in the management of acute pulmonary thromboembolism
CLINICAL RESPIRATORY JOURNAL
Cilt 12 · Sayı 4 · ss. 1628–1634 · 01.04.2018
Özet
BackgroundPulmonary thromboembolism (PTE) is a life-threatening disease. In this study, we aimed to evaluate long-term outcomes of the use of 50mg recombinant tissue-type plasminogen activator (rt-PA) in the management of PTE in terms of relapse, pulmonary hypertension (PH), mortality and hemorrhage and to compare with the use of 100mg rt-PA.
Anahtar kelimeler
Pulmonary thromboembolism
THROMBOLYTIC THERAPY
long-term outcomes
Atıf için künye
Yılmazel Uçar, E., Araz, Ö., KERGET, B., YILMAZ, N., AKGÜN, M., & Sağlam, L. (2018). Comparison of long-term outcomes of 50 and 100mg rt-PA in the management of acute pulmonary thromboembolism. CLINICAL RESPIRATORY JOURNAL, 12(4), 1628–1634. https://doi.org/10.1111/crj.12721
BibTeX
@article{yilmazelucar2018-226937,
author = {Yılmazel Uçar, Elif and Araz, Ömer and KERGET, Buğra and YILMAZ, Nafiye and AKGÜN, Metin and Sağlam, Leyla},
title = {Comparison of long-term outcomes of 50 and 100mg rt-PA in the management of acute pulmonary thromboembolism},
journal = {CLINICAL RESPIRATORY JOURNAL},
year = {2018},
volume = {12},
number = {4},
pages = {1628--1634},
issn = {1752-6981},
doi = {10.1111/crj.12721},
url = {https://akademik.atauni.edu.tr/yayinlar/226937-comparison-of-long-term-outcomes-of-50-and-100mg-rt-pa-in-the-management-of}
}